SCHEMBL24592467

SCHEMBL24592467

CCNc1nn(CC(C)(C)c2c(C)ccc3[nH]nc(N(C)C)c23)c2ccc(C)c(C(C)(C)C)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22349083 0.76 MAPK1 (0.32) —
SCHEMBL22349084 0.72 MAPK1 (0.35) —
SCHEMBL22924147 0.72 — —
SCHEMBL22924098 0.71 LCK (0.32) —
SCHEMBL20970415 0.69 KDR (0.31) —
SCHEMBL22924139 0.69 — —
SCHEMBL22924101 0.66 — —
SCHEMBL24592385 0.62 — —
SCHEMBL22328045 0.61 ADRA2A (0.35) —
SCHEMBL19104231 0.61 MAPK1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377441-B2 Covalent inhibitors of KRAS ARAXES PHARMA LLC (US) 2022-07-05 — — US disclosed
Send feedback